Eagle Bay Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Eagle Bay Advisors's GILD Position: Q1 2025 in Review
Eagle Bay Advisors sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 1,138 shares — an estimated $105K sold.
Eagle Bay Advisors first reported a position in GILD in Q2 2021 and held it in 15 quarters. The position peaked at $142K in Q3 2021. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- Eagle Bay Advisors reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
- Eagle Bay Advisors sold 1,138 Gilead Sciences shares in Q1 2025, an estimated $105K.
- Eagle Bay Advisors first reported a position in Gilead Sciences in Q2 2021 and held it in 15 quarters.
- Eagle Bay Advisors's Gilead Sciences position peaked at $142K in Q3 2021.
- 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.